AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 11 min read$RCMT

MILLER KEVIN D sold $949K of RCMT

MILLER KEVIN D (CFO) sold 22,501 shares of RCM TECHNOLOGIES, INC. (RCMT) at an average of $42.17 ($42.00–$42.19, $0.95M total) across 2 trades over 2026-08-28 to 2026-08-31 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · MILLER KEVIN D
Published Sep 1, 2026, 8:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 9:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$RCMT
Neutral
high confidence
Mentioned
$RCMT
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RCMTNeutralLow
01

Why it matters

The CFO's sale is routine and unlikely to affect RCMT's valuation.

02

Market read

Low relevance; the disclosed trade is modest and pre‑arranged.

03

What to watch

Potential tax planning or portfolio rebalancing rather than loss of confidence.

Relevance 4/10Novelty 4/10Timing: after market close

Background

Form 4 filings disclose insider trades; investors monitor them for signals.

Company-level read

Ticker impact

$RCMTNeutralHigh confidence
Context

CFO Kevin D. Miller sold 22,501 shares for $948,893 via a 10b5‑1 plan.

Expected impact

No material move expected.

Evidence & confidence

Sale size is under $1M and follows a pre‑arranged plan, typical for insiders.

Market effects

Sector

None; the transaction is company‑specific.

Regional

None; limited to RCMT shareholders.

Global

None

Counterpoint

What could challenge this read

The sale could signal upcoming weakness, but size is too small to matter.

Key entities

  • person
    Kevin D. Miller

    Chief Financial Officer of RCM Technologies, Inc.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

RCMT insider trading history →

Related articles

OCT 27
$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).

SEC EDGAR1 min